Member Info for jimmy2011

Also watch out for 26mill sell, 20k be bought later and isa'd..

A few things lineing up here with sgsc, and I think professor evens may be setting up to have his fist in someway or other via igaine.
Gla

leval 2 showing 4 buyers / 3 sellers.
0.075/0.085.
buyers still out there, just trying to take advantage of drop in market.
gla

false drop,
took a little 484,737 top up.
gla

This is what you call, squeaky bum time.
Only the brave will hold and build.
Gla.

Dr Riley referenced "early reports" where up to five percent of Covid patients went on to develop diabetes seven months after being discharged from hospital.

"People who’d been in hospital with coronavirus were 1.5 times more likely to be diagnosed with diabetes after they’d been discharged," said Dr Riley.

This was in comparison to "people of the same age and background who hadn’t been in hospital with coronavirus".

nicely , mwe, but still needs another 10% ish for vela to be even,
got in a couple of weeks back @ 61, so im not complaining,
mm's can not hold this much longer, surely,
gla

im going,
0.0875 open,
0.0925 close,
news over week end,
2-1 england,
gla

i dont know if im right, but , i look at 16.07, then 15.07 and see if the price slots in, and any flicker in sp, you can 9 out of 10 make a educated guess, i think 16.07, and mm's took a hr to fill/ show it.
ive noticed this a lot, also a 9 min gap of trades with no action after a flurry of buys.
my thinking may be wrong, but entertains me, lol
gla tick up on open?

there she goes, the little bugger i was expecting, 36 mill buy,i had a feeling there was a big buy going through.
gla

some good double figs, comeing in in the mills, buys 0.0865 + range, good chance to finish close to 0.09 and over today as the clock ticks,
gla

Today, so results can land any time here on,
Gla

The RNS below from Angelfish investments, listed on Aquis, makes for very interesting reading for Vela shareholders. Is this a signal that the ARCADIA trial is proving positive with just 2 weeks to go to the end of the trial?

https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=ANGP

No one seems to have picked this news up?

In short, Angelfish Investments announced on Friday a major reorganisation, including raising £2m and bringing Professor Sir Christopher Evans on to the Board together with other Excalibur Healthcare Services Directors and founders.

Excalibur has exclusive rights to and owns the patents on a drug, AZD1656, which is being developed as a potential therapeutic for diabetics suffering from COVID-19.

Professor Sir Christopher Evans structured the ARCADIA research project from which St George’s Capital is hoping to be able to commercialise.

The announcement also goes into great detail about AZD1656 and the ARCADIA trial.

So, the question is, why would Professor Sir Christopher Evans be doing such a transaction at this time, right at the end of the trial, if he did not hold out very high expectations that the trial results would be positive?

panamabob, i think the proof in the pudding will be over next couple of trading days as the posted rns is digested by the big boys,
i have read it over and over,
the more i read, the more im convinced,
WE ARE ON A WINNER,
and evans and nomand will know its out the bag,
also,
thanks to all today for your lovely comments and remarks,
its made me so happy to be able to contribute something of importance,
although it was a copy and paste,
but thanks,
gla jimmy,

Credit goes to edcrane on advfn copy and pasted ,
Gla

The RNS below from Angelfish investments, listed on Aquis, makes for very interesting reading for Vela shareholders. Is this a signal that the ARCADIA trial is proving positive with just 2 weeks to go to the end of the trial?

https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=ANGP

No one seems to have picked this news up?

In short, Angelfish Investments announced on Friday a major reorganisation, including raising £2m and bringing Professor Sir Christopher Evans on to the Board together with other Excalibur Healthcare Services Directors and founders.

Excalibur has exclusive rights to and owns the patents on a drug, AZD1656, which is being developed as a potential therapeutic for diabetics suffering from COVID-19.

Professor Sir Christopher Evans structured the ARCADIA research project from which St George’s Capital is hoping to be able to commercialise.

The announcement also goes into great detail about AZD1656 and the ARCADIA trial.

So, the question is, why would Professor Sir Christopher Evans be doing such a transaction at this time, right at the end of the trial, if he did not hold out very high expectations that the trial results would be positive?

looking at todays trades, i would say theres been quite a few biggish trades smuggled in the mix ?
gla

such a pleasant board i find, no one egar to pull you down if your spelling or maths is not up to every ones exportations, just accepted for a opinion, as its a opinion board, not a o,level in english or maths,
i hope all had a plesant weekend, and can keep there calm for what ever the market games are thrown at us, because us belivers know we are on a winner, its a massive hold and build from me.
gla

opps, two years time.

is being watered by james nomand, thats how i see vela, slowly growing into a strong oak tree, i see this at 50p plus in tow years with a 500/1 consolidation,
gla